Defining the Incidence and Clinical Impact of Genomic Alterations Across Different Histologic Types of Lymphoma Using a Clinically Validated Comprehensive Targeted Sequencing Assay by Batlevi, Connie, Rapaport, Franck, Intlekofer, Andrew M., Reiner, Anne, Moskowitz, Craig H, Horwitz, Steven M, Zelenetz, Andrew D, Palomba, Lia, Moskowitz, Alison J, Gerecitano, John F., Hamlin, Paul A, Copeland, Amanda R., Matasar, Matthew J, Sauter, Craig S., Kumar, Anita, Noy, Ariela, Straus, David J., Portlock, Carol S., Criscuolo, Frederick, He, Jie, Royston, Daniel, Balasubramanian, Sohail, Reznikovskaya, Yekaterina, Pichardo, Janine D., Stephens, Phil, Miller, Vincent, Levine, Ross L., Seshan, Venkatraman, Dogan, Ahmet, Younes, Anas

Get full text